Kai Yu

Kai Yu

Auto-generated profile, based on publicly available information

Kai Yu

Division of Cancer Epidemiology and Genetics, National Cancer Institute , Rockville, MD

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 March 2009 in Genetic Epidemiology
Verified
Journal Article
Open access
PDF file
KYKai Yu
Kai Yu
QLQizhai Li
Qizhai Li
ABAndrew W Bergen
Andrew W Bergen
RPRuth M. Pfeiffer
Ruth M. Pfeiffer
PRPhilip S. Rosenberg
Philip S. Rosenberg
NCNilanjan Chatterjee
Nilanjan Chatterjee
It is increasingly recognized that pathway analyses—a joint test of association between the outcome and a group of single nucleotide polymorphisms (SNPs) within a biological pathway—could potentially complement single‐SNP analysis and provide additional insights for the genetic architecture of complex diseases. Building upon existing P‐value combining methods, we propose a class of highly flexible pathway analysis approaches based on an adaptive rank truncated product statistic that can effectively combine evidence of associations over different SNPs and genes within a pathway. The statistical significance of the pathway‐level test statistics is evaluated using a highly efficient permutation algorithm that remains computationally feasible irrespective of the size of the pathway and complexity of the underlying test statistics for summarizing SNP‐ and gene‐level associations. We demonstrate through simulation studies that a gene‐based analysis that treats the underlying genes, as opposed to the underlying SNPs, as the basic units for hypothesis testing, is a very robust and powerful approach to pathway‐based association testing. We also illustrate the advantage of the proposed methods using a study of the association between the nicotinic receptor pathway and cigarette smoking behaviors. Genet. Epidemiol. 33:700–709, 2009. Published 2009 Wiley‐Liss, Inc.

20 September 2009 in Nature Genetics
Verified
Journal Article
Open access
PDF file
MYMeredith Yeager
Meredith Yeager
NCNilanjan Chatterjee
Nilanjan Chatterjee
JCJulia Ciampa
Julia Ciampa
KJKevin B Jacobs
Kevin B Jacobs
JBJesus Gonzalez Bosquet
Jesus Gonzalez Bosquet
SCStephen J. Chanock
Stephen J. Chanock
Meredith Yeager and colleagues with the Cancer Genetics Markers of Susceptibility (CGEMS) initiative report a new association to prostate cancer at chromosome 8q24. This defines a new locus, region 4, which shows association to prostate cancer susceptibility independent of previously reported associations at 8q24. We report a genome-wide association study in 10,286 cases and 9,135 controls of European ancestry in the Cancer Genetic Markers of Susceptibility (CGEMS) initiative. We identify a new association with prostate cancer risk on chromosome 8q24 (rs620861, P = 1.3 × 10−10, heterozygote OR = 1.17, 95% CI 1.10–1.24; homozygote OR = 1.33, 95% CI 1.21–1.45). This defines a new locus associated with prostate cancer susceptibility on 8q24.


2 July 2008 in PLOS ONE
Verified
Journal Article
Open access
PDF file
KYKai Yu
Kai Yu
ZWZhaoming Wang
Zhaoming Wang
QLQizhai Li
Qizhai Li
SWSholom Wacholder
Sholom Wacholder
DHDavid J. Hunter
David J. Hunter
GTGilles Thomas
Gilles Thomas
Determination of the relevance of both demanding classical epidemiologic criteria for control selection and robust handling of population stratification (PS) represents a major challenge in the design and analysis of genome-wide association studies (GWAS). Empirical data from two GWAS in European Americans of the Cancer Genetic Markers of Susceptibility (CGEMS) project were used to evaluate the impact of PS in studies with different control selection strategies. In each of the two original case-control studies nested in corresponding prospective cohorts, a minor confounding effect due to PS (inflation factor λ of 1.025 and 1.005) was observed. In contrast, when the control groups were exchanged to mimic a cost-effective but theoretically less desirable control selection strategy, the confounding effects were larger (λ of 1.090 and 1.062). A panel of 12,898 autosomal SNPs common to both the Illumina and Affymetrix commercial platforms and with low local background linkage disequilibrium (pair-wise r2<0.004) was selected to infer population substructure with principal component analysis. A novel permutation procedure was developed for the correction of PS that identified a smaller set of principal components and achieved a better control of type I error (to λ of 1.032 and 1.006, respectively) than currently used methods. The overlap between sets of SNPs in the bottom 5% of p-values based on the new test and the test without PS correction was about 80%, with the majority of discordant SNPs having both ranks close to the threshold. Thus, for the CGEMS GWAS of prostate and breast cancer conducted in European Americans, PS does not appear to be a major problem in well-designed studies. A study using suboptimal controls can have acceptable type I error when an effective strategy for the correction of PS is employed.

15 April 2020 in Biometrika
Verified
Journal Article
Closed access
PDF file
HZHan Zhang
Han Zhang
LDLu Deng
Lu Deng
MSMark Schiffman
Mark Schiffman
JQJing Qin
Jing Qin
KYKai Yu
Kai Yu
Summary: Meta-analysis has become a powerful tool for improving inference by gathering evidence from multiple sources. It pools summary-level data from different studies to improve estimation efficiency with the assumption that all participating studies are analysed under the same statistical model. It is challenging to integrate external summary data calculated from different models with a newly conducted internal study in which individual-level data are collected. We develop a novel statistical inference framework that can effectively synthesize internal and external data for the integrative analysis. The new framework is versatile enough to assimilate various types of summary data from multiple sources. We establish asymptotic properties for the proposed procedure and prove that the new estimate is theoretically more efficient than the internal data based maximum likelihood estimate, as well as a recently developed constrained maximum likelihood approach that incorporates the external information. We illustrate an application of our method by evaluating cervical cancer risk using data from a large cervical screening program.

3 March 2008 in Annals of Human Genetics
Verified
Journal Article
Closed access
PDF file
QLQizhai Li
Qizhai Li
GZGang Zheng
Gang Zheng
ZLZhaohai Li
Zhaohai Li
KYKai Yu
Kai Yu